1. Home
  2. EPM vs NKTX Comparison

EPM vs NKTX Comparison

Compare EPM & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

N/A

Current Price

$3.76

Market Cap

136.3M

Sector

Energy

ML Signal

N/A

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$1.82

Market Cap

133.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EPM
NKTX
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.3M
133.5M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EPM
NKTX
Price
$3.76
$1.82
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$4.75
$13.25
AVG Volume (30 Days)
426.6K
623.5K
Earning Date
11-11-2025
11-10-2025
Dividend Yield
12.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$85,232,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$1.31
52 Week High
$5.70
$2.74

Technical Indicators

Market Signals
Indicator
EPM
NKTX
Relative Strength Index (RSI) 32.91 43.79
Support Level $3.75 $1.80
Resistance Level $4.27 $1.90
Average True Range (ATR) 0.11 0.07
MACD -0.01 0.01
Stochastic Oscillator 2.91 42.50

Price Performance

Historical Comparison
EPM
NKTX

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: